(Q38674929)

5 September 2017

1 reference

title

Mechanisms of immunity to malaria and the possibilities of a blood-stage vaccine: a critical appraisal (English)

1 reference

5 September 2017

1 reference

1 reference

Butcher GA

1

1 reference

5 September 2017

1 April 1989

1 reference

5 September 2017

1 reference

5 September 2017

98 Pt 2

1 reference

5 September 2017

315-327

1 reference

Malaria invasion of human erythrocytes.

5 September 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Antigenic variation of cloned Plasmodium fragile in its natural host Macaca sinica. Sequential appearance of successive variant antigenic types

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Immunity to Plasmodium chabaudi adami in the B-cell-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Surface antigens of malaria merozoites. A high molecular weight precursor is processed to an 83,000 mol wt form expressed on the surface of Plasmodium falciparum merozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Action of Malarial Antibody in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Heterologous immunity in human malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

The interferon compartment of the immune response in human malaria: I. Interferon inducers in Plasmodium falciparum cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

The dependence of cell-mediated immune activation in malaria on age and endemicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Properties of protective malarial antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Toxicity of certain products of lipid peroxidation to the human malaria parasite Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Immunity to malaria. 3. Possible occurrence of a cell-mediated immunity to Plasmodium knowlesi in chronically infected and Freund's complete adjuvant-sensitized monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Inhibition of P. falciparum growth in human erythrocytes by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Immunization with a Plasmodium falciparum merozoite surface antigen induces a partial immunity in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Cell-mediated immunity in protection and pathology of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Apparent irrelevance of NK cells to resolution of infections with Babesia microti and Plasmodium vinckei petteri in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Induction of protective immunity against experimental infection with malaria using synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Passive immunity in Plasmodium knowlesi malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Structure and development of the surface coat of erythrocytic merozoites of Plasmodium knowlesi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Induction of crisis forms in cultured Plasmodium falciparum with human immune serum from Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Merozoite vaccination of douroucouli monkeys against falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Protective antigen in the membranes of mouse erythrocytes infected with Plasmodium chabaudi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Genetic analysis of the human malaria parasite plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Immunological studies on simian malaria. 3. Immunity to challenge and antigenic variation in P. knowlesi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Immunological studies on simian malaria parasites IV. Heterologous superinfection of monkeys with chronic Plasmodium knowlesi infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Human monoclonal antibodies to Pf 155, a major antigen of malaria parasite Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Inhibition of intra-erythrocytic growth of Plasmodium falciparum by human sera from Papua New Guinea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Non-specific immunity to Plasmodium falciparum: in vitro studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Malaria. Effective vaccine for humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Absence of crisis form factor in subjects immune to Plasmodium falciparum in The Gambia, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Repetitive proteins and genes of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Antigen presentation and the response to parasitic infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Comparison of immunity to malaria in Sudan and Indonesia: crisis-form versus merozoite-invasion inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Plasmodium berghei: Relationship between protective immunity and anti-sporozoite (CSP) antibody in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Murine malaria: dissociation of natural killer (NK) cell activity and resistance to Plasmodium chabaudi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Cellular mechanisms involved in recovery from acute malaria in Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

An Effective Immunization of Experimental Monkeys Against a Human Malaria Parasite, Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Cellular and humoral inhibition of Plasmodium falciparum growth in vitro and recovery from acute malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Kinetic constraints on the development of a malaria vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Protective immunity to malaria. Studies with cloned lines of Plasmodium chabaudi chabaudi and P. berghei in CBA/Ca mice. II. The effectiveness and inter- or intra-species specificity of the passive transfer of immunity with serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

The Role of Cell-Mediated Immune Responses in Resistance to Malaria, with Special Reference to Oxidant Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Expression of strain-specific surface antigens on Plasmodium falciparum-infected erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Surface alterations of erythrocytes in Plasmodium falciparum malaria. Antigenic variation, antigenic diversity, and the role of the spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Protective antigens of rodent and human bloodstage malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Method to test inhibitory antibodies in human sera to wild populations of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

Factors contributing to the development of cerebral malaria. I. Humoral immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

The effect of mosquito transmission of antigenic variants of Plasmodium chabaudi

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

https://api.crossref.org/works/10.1017%2FS0031182000062247

1 reference

7 January 2021

Association between human serum-induced crisis forms in cultured Plasmodium falciparum and clinical immunity to malaria in Sudan

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

Continuous temperature measurements during malaria infections

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

In vitro isolation of Plasmodium knowlesi merozoites using polycarbonate sieves.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

The development and ultrastructure of Plasmodium falciparum damaged in vitro by human "crisis" sera and by chloroquine

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

Short-term culture of Plasmodium knowlesi

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

Inhibition of growth in vitro of Plasmodium falciparum by complex polysaccharides

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

The behaviour of different strains of Plasmodium falciparum in suspension and static culture

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

Immunization of mice against blood-stage Plasmodium yoelii malaria with isoelectrically focused antigens and correlation of immunity with T-cell priming in vivo

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

The importance of parasite load in the killing of Plasmodium vinckei in mice treated with Corynebacterium parvum or alloxan monohydrate

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

Oxygen-derived free radicals in the pathogenesis of parasitic disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

Murine malaria: resistance of AXB/BXA recombinant inbred mice to Plasmodium chabaudi

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

Killing of blood-stage murine malaria parasites by hydrogen peroxide.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182000062247

7 January 2021

10.1017/S0031182000062247

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

2668863